Breast Cancer, Male - 25 Studies Found Recruiting : Tamoxifen +/- GnRH Analogue vs Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients : Male Breast Cancer : 2012-07-09 : Drug: Tamoxifen 25 mg daily. Active, not recruiting : Finasteride (MK-0906) and Male Breast Cancer - A Register-Based Nested Case-Control Study (MK-0906-162/2003.021). : Male Breast Cancer : 2012-09-24 Completed : Male Breast Cancer Summa Health System/Akron City Hospital Experience 1995-2007 : Breast Cancer : 2008-10-15 Completed : Sense of Hope Alleviates Fatigue in Breast Cancer Survivors : Carcinoma of Male Breast : 2015-01-06 Active, not recruiting : Male Breast Cancer: Understanding the Biology for Improved Patient Care : Breast Cancer : 2010-04-09 Not yet recruiting : Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer : Breast - Female Male Breast Cancer : 2017-01-10 : Drug: Pembrolizumab IV (in the Active, not recruiting : Silent Breast Cancer A Study of the Disease Prevalence Held by Imaging Guided Biopsies in Autopsy Specimens : Female Breast Cancer Male Breast Cancer : 2015-06-17 : Procedure: Bilateral mastectomy Active, not recruiting : Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Hormone Therapy : Male Breast Cancer Recurrent Breast Cancer Drug: vorinostat Given PO Active, not recruiting : Vorinostat in Treating Patients With Stage IV Breast Cancer Receiving Aromatase Inhibitor Therapy : Male Breast Cancer Recurrent Breast Cancer Drug: vorinostat Given PO Active, not recruiting : Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer : Male Breast Cancer Recurrent Breast Cancer Drug: vorinostat Given orally Next >>>
